Overview
Administration
CU Symbols
GREEN UNIVERSITY
CONTACT
Programs
Admissions
Exchange Student
Academic Units
Life at CU
Academic Services
Medical Services
Quality Assurance Services
Information Services
Creative Space
CU News
15 May 2019
Featured News
On Tuesday, 23 April 2019, Professor Suttipong Wacharasindhu, Director of King Chulalongkorn Memorial Hospital and Dean of Faculty of Medicine at Chulalongkorn University, along with Dr. Sirasak Teparkum, Deputy CEO at the Thailand Center of Excellence of Life Sciences, Dr. Koramit Suppitpat, Head of Research on Cell Therapy for Cancer Patients at Chulalongkorn University, Assistant Professor Dr. Udomsak Bunworasate, Head of Hematology Department at Chulalongkorn University, and Professor Nattiya Hirankarn, Assistant Dean for Research at the Faculty of Medicine at Chulalongkorn University, announced the first milestone in using natural killer cells to prevent cancer relapse in acute myeloid leukemia patients.
Natural killer cells are a type of white blood cells that are crucial to the immune system but only make up about 5–10% of all the white blood cells in a human body. The main role of a natural killer cell is to target malignant cells or cells with potentially harmful genetic abnormalities. These cells are usually virus-infected and may develop into tumor or cancer. The natural killer cells serve to destroy these foreign cells and clear the infection.
Regardless, due to the limited amount of natural killer cells that can be produced in humans, the killer cells have to be cultured in a lab, where the cells can be stimulated, multiplied, and grown outside of the body. Although the natural killer cells are proven to have special characteristics to eradicate cancer cells, studies have only proven this result in acute myeloid leukemia patients.
The Chula research team has initiated a clinical trial with a group of five acute myeloid leukemia patients. The patients have been treated with natural killer cells from donors. All of the patients were prospects of cancer relapse and previously did not respond well to standard treatment options. Through the clinical trial, these lab-grown donor killer cells were transferred back into the patients to kill malignant cells. To date, the project results have been positive and the research team will move forward with the next stages of treatment and monitoring of the killer cells’ effectiveness in leukemia patients.
Apart from the research on treatment for acute myeloid leukemia patients, the research center has also developed cancer treatment methods using chimeric antigen receptor T-cells: CAR T-cells for leukemia and lymphoid lymphoma patients, virus specific T-cells for the treatment of viral infections after hematopoietic stem cell transplants or nasopharyngeal cancer, and dendritic cell vaccines.
“CU Blood Dare to Give” Chula Invites Blood Donations to Empower the Spirit of Giving and Save Lives
Friday, November 22, 2024, from 11:00 AM to 7:00 PM
the Block I Square, Siam Square, Bangkok, Thailand
The Parent and Teacher Association of Chula Demonstration School Donates 3 Million Baht to “Chamchuri United” Football Club
Energy Transition & Achieving Net Zero Greenhouse Gas Emissions by 2050: Part 1
Thailand-Türkiye Friendship Concert: A Musical Collaboration to Celebrate Relations Between Thailand and Turkey
MOU Signing Between CSII and Bank of Ayudhya (BAY)
Navigating the Midpoint of the UN SDGs: A Special Lecture by Prof. Masamine Jimba
Friday, November 22, 2024, at 10:00 AM
True Auditorium, Building 3, Faculty of Engineering, Chulalongkorn University
The sense of kinship and warmth found in the Chula community is priceless and a treasure worth keeping. Prof. Dr. Pornanong Aramwit Faculty of Pharmaceutical Sciences, Chulalongkorn University
The sense of kinship and warmth found in the Chula community is priceless and a treasure worth keeping.
Prof. Dr. Pornanong Aramwit Faculty of Pharmaceutical Sciences, Chulalongkorn University
This website uses cookies to personalize content, provide the best user experience, and improve Chula website services.
ท่านสามารถเลือกการตั้งค่าคุกกี้โดยเปิด/ปิด คุกกี้ในแต่ละประเภทได้ตามความต้องการ ยกเว้น คุกกี้ที่จำเป็น
ประเภทของคุกกี้ที่มีความจำเป็นสำหรับการทำงานของเว็บไซต์ เพื่อให้คุณสามารถใช้เว็บไซต์ได้อย่างเป็นปกติ ท่านไม่สามารถปิดการทำงานของคุกกี้นี้ในระบบเว็บไซต์ของเราได้
คุกกี้ประเภทนี้จะทำการเก็บข้อมูลพฤติกรรมการใช้งานเว็บไซต์ของคุณ โดยมีจุดประสงค์คือนำข้อมูลมาวิเคราะห์เพื่อปรับปรุงและพัฒนาเว็บไซต์ให้มีคุณภาพ และสร้างประสบการณ์ที่ดีกับผู้ใช้งาน เพื่อให้เกิดประโยชน์สูงสุด หากท่านไม่ยินยอมให้เราใช้คุกกี้นี้ เราอาจไม่สามารถวัดผลเพื่อการปรับปรุงและพัฒนาเว็บไซต์ให้ดีขึ้นได้ Cookies Details